IBM Micromedex Drug Int.
Free
2.2.0for iPhone, iPad
Age Rating
IBM Micromedex Drug Int. Screenshots
About IBM Micromedex Drug Int.
IBM Micromedex Drug Int. app is free to subscribers of IBM Micromedex Drug Int. online.
With IBM Micromedex Drug Int., clinicians can check a patient’s entire medication list simultaneously for potentially harmful interactions and view severity ratings that range from contraindicated to minor. This app provides insight into:
• Why the drugs in question interact.
• How the results of those interactions will present in the patient.
• Recommendations for monitoring patient outcomes.
IBM Micromedex Drug Int. is a reliable resource for on-the-go access to the industry’s most trusted clinical reference information, providing users with more informed treatment decisions at the point of care. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Not sure if your institution subscribes to IBM Micromedex via the internet? Check with your Chief Medical Officer, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If the facility you work at subscribes to IBM Micromedex via the internet, follow these instructions to obtain a password:
1.Login to IBM Micromedex through your subscribing facility
2.Click on the “Download Center” link near the top of the application
3.Refer to the detailed downloading instructions, which include your password for activating the application at no charge.
If you cannot locate the “Download Center” link please contact support at https://developer.ibm.com/watsonhealth/micromedex-support/
Email Address: ProductSupport@Merative.com
Phone number: US and Canada 1.877.843.6796
Global : +1.303.354.4100 ,Press Option 2
Existing paid customers will continue to have access to the content going forward.
With IBM Micromedex Drug Int., clinicians can check a patient’s entire medication list simultaneously for potentially harmful interactions and view severity ratings that range from contraindicated to minor. This app provides insight into:
• Why the drugs in question interact.
• How the results of those interactions will present in the patient.
• Recommendations for monitoring patient outcomes.
IBM Micromedex Drug Int. is a reliable resource for on-the-go access to the industry’s most trusted clinical reference information, providing users with more informed treatment decisions at the point of care. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Not sure if your institution subscribes to IBM Micromedex via the internet? Check with your Chief Medical Officer, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If the facility you work at subscribes to IBM Micromedex via the internet, follow these instructions to obtain a password:
1.Login to IBM Micromedex through your subscribing facility
2.Click on the “Download Center” link near the top of the application
3.Refer to the detailed downloading instructions, which include your password for activating the application at no charge.
If you cannot locate the “Download Center” link please contact support at https://developer.ibm.com/watsonhealth/micromedex-support/
Email Address: ProductSupport@Merative.com
Phone number: US and Canada 1.877.843.6796
Global : +1.303.354.4100 ,Press Option 2
Existing paid customers will continue to have access to the content going forward.
Show More
What's New in the Latest Version 2.2.0
Last updated on Oct 31, 2022
Old Versions
• Updates in preparation for the sunsetting of the app. For more information, email our team with questions at: ProductSupport@Merative.com
Show More
Version History
2.2.0
Oct 31, 2022
• Updates in preparation for the sunsetting of the app. For more information, email our team with questions at: ProductSupport@Merative.com
2.1.1
Aug 16, 2022
• Bug fixes
2.1.0
Jul 19, 2022
• In-app link fixes between IBM Micromedex applications.
• New support email address to associate with our new company.
• New support email address to associate with our new company.
2.0.3
Feb 14, 2022
• Security Updates
2.0.1
Dec 10, 2020
Critical bug fixes and enhanced security and stability of the application.
1.62.5
Sep 28, 2020
Upgraded to work with a new subscription service to ease the renewal process.
Critical bug fixes and enhanced security and stability of the application.
Added Support for Dark Mode for iOS 13.0 or later.
Critical bug fixes and enhanced security and stability of the application.
Added Support for Dark Mode for iOS 13.0 or later.
1.62.2
Oct 23, 2019
Defect fix for new iOS version
1.62.1
Dec 19, 2018
Defect Fixes
1.62.0
Aug 21, 2018
Required End User License Agreement (EULA) includes branding updates.
1.61.5
Apr 26, 2018
IBM Rebranding
1.61.4
Feb 28, 2018
In-App Linking between Micromedex Drug Interactions and Micromedex IV Compatibility.
o Updated functionality that allows for streamlined acquisition of clinically relevant information between applications
o Functionality allows navigation between applications with carrying forward of initial drug(s) search
o Updated functionality that allows for streamlined acquisition of clinically relevant information between applications
o Functionality allows navigation between applications with carrying forward of initial drug(s) search
1.61.2
Nov 30, 2017
In-App Linking between Micromedex Drug Reference (or Micromedex Drug Info – Mobile) and Micromedex Drug Interactions
o Updated functionality that allows for streamlined acquisition of clinically relevant information between applications
o Functionality allows navigation between applications with carrying forward of initial drug search
o For detailed workflow documentation please see: http://truvenhealth.com/portals/0/assets/MM_InAppLinkingWorkflow.pdf
o Updated functionality that allows for streamlined acquisition of clinically relevant information between applications
o Functionality allows navigation between applications with carrying forward of initial drug search
o For detailed workflow documentation please see: http://truvenhealth.com/portals/0/assets/MM_InAppLinkingWorkflow.pdf
1.61.1
Aug 19, 2017
Updated Copyright information
1.61.0
Jul 3, 2017
- Bug Fixes
1.60.0
May 19, 2017
- Enhanced the Performance of the application
- Bug fixes
- Bug fixes
1.59.0
Oct 1, 2016
Drug Content Updates.
1.58.0
Jun 8, 2016
Drug content update.
1.57.0
Mar 17, 2016
Quarterly Content Update
1.56.0
Dec 12, 2015
Drug content update.
1.53.5
Jul 31, 2015
Drug content updates.
1.52.5
May 21, 2015
Drug content updates.
1.52.4
Feb 28, 2015
updated content
1.52.3
Dec 4, 2014
content update
1.52.2
Sep 29, 2014
content update
1.52.1
Jun 1, 2014
bug fixes
1.52.0
May 22, 2014
updated content
1.51.0
Mar 26, 2014
updated content
1.50.0
Dec 2, 2013
Updated Content
1.49.0
Oct 28, 2013
updated content
1.46.0
Apr 24, 2013
update
1.45.0
Feb 20, 2013
Updated with v1560 data
1.44.0
Dec 17, 2012
As you may be aware, Thomson Reuters Healthcare has a new name: Truven Health Analytics. While we have a new name and new branding in this release, the functionality of the application has not changed.
IBM Micromedex Drug Int. FAQ
Click here to learn how to download IBM Micromedex Drug Int. in restricted country or region.
Check the following list to see the minimum requirements of IBM Micromedex Drug Int..
iPhone
iPad
IBM Micromedex Drug Int. supports English